Mostrar el registro sencillo del ítem
dc.contributor.author | Kochen, Silvia | |
dc.date.accessioned | 2019-03-26T14:26:18Z | |
dc.date.available | 2019-03-26T14:26:18Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Kochen, Silvia. Uso del cannabis en la Epilepsia. Situación actual a nivel internacional y en nuestro país.Vertex; XXVII(130): 457-462, 2016 Nov. | es_AR |
dc.identifier.uri | http://www.polemos.com.ar/vertex130.php | |
dc.identifier.uri | http://repositorio.hospitalelcruce.org/xmlui/handle/123456789/782 | |
dc.description | Fil: Kochen, S. Hospital de Alta Complejidad en Red El Cruce Dr. Néstor C. Kirchner. Centro Nacional de Alta Complejidad en Neurociencias y Neurocirugía. Florencio Varela, Argentina. | es_AR |
dc.description.abstract | Although at present we have over 20 different types of drugs for epilepsy, 30 to 40% of patients continue to have seizures. Preliminary data from human studies suggest that cannabis, cannabidiol in particular, is effective in the treatment of some patients with epilepsy. However, the available data are limited and do not allow defnitive conclusions. Only randomized clinical trials with controlled double-blind, placebo-controlled utilizing secure preparations and one or more cannabinoids, will provide comprehensive information on the effcacy and safety of use. In order to perform these trials it is necessary to have legislation authorizing the use of cannabis on epilepsy. | es_AR |
dc.language.iso | es | es_AR |
dc.publisher | Polemos | es_AR |
dc.relation.ispartofseries | Vertex;XXVII(130): 457-462, 2016 Nov. | |
dc.subject | Epilepsia | es_AR |
dc.subject | Marihuana Medicinal | es_AR |
dc.subject | Medical Marijuana | es_AR |
dc.subject | Epilepsy | es_AR |
dc.subject | Argentina | es_AR |
dc.subject | Cannabinoides | es_AR |
dc.subject | America Latina | es_AR |
dc.title | Uso del cannabis en la Epilepsia. Situación actual a nivel internacional y en nuestro país | es_AR |
dc.type | Article | es_AR |